Is PSMA PET Scan Covered By Medicare?
FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer. June 28, 2021 — The U.S. Food and Drug Administration (FDA) approved a new imaging agent for detection of prostate cancer, providing a more effective imaging approach to detect the spread of cancer to other parts of theRead More →